Search

RADNOR: Mineralys Therapeutics, Inc. has issued the following news release: Mineralys Therapeutics, Inc. (Nasdaq: MLYS), a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension, chronic kidney disease (CKD) [...]

Overview Type 1 diabetes, once known as juvenile diabetes or insulin-dependent diabetes, is a chronic condition. In this condition, the pancreas makes little or no insulin. Insulin is a hormone [...]

Having high blood pressure (hypertension) during pregnancy needs close monitoring. Here's what to know about the potential risks. Also learn how to take care of yourself and your baby. What [...]

Azilsartan Medoxomil and Chlorthalidone Tablets had annual sales of $77.9 million in the United States Zydus Lifesciences has received tentative approval from the United States Food and Drug Administration (USFDA) [...]

Azilsartan Medoxomil and Chlorthalidone Tablets had annual sales of $77.9 million in the United States Zydus Lifesciences is currently trading at Rs. 1103.45, up by 13.15 points or 1.21% from [...]

Nearly all experts agree that we should eat less salt. But opposition from the food industry and a handful of scientists has stalled efforts to cut the salt in the [...]

Byline: Haider J. Warraich As the novel coronavirus spreads around the world, it primarily sickens people by affecting their lungs. But it is now becoming clear that the finishing blow [...]

Keeping blood pressure in check may lower the risk of Alzheimer's disease and other forms of dementia. Controlling blood pressure in middle age may reduce the risk for dementia. The [...]

(GLOBE NEWSWIRE via COMTEX) -- - The Committee voted 12 to 1 that the data presented support the use of Entresto in treatment of patients with heart failure with preserved [...]

PALO ALTO: ReCor Medical, Inc. has issued the following news release: ReCor Medical, Inc. ('ReCor'), a wholly-owned subsidiary of Otsuka Medical Devices, announced today that its Paradise Ultrasound Renal Denervation [...]

ReCor Medical, Inc. ('ReCor'), a wholly-owned subsidiary of Otsuka Medical Devices, announced today that its Paradise Ultrasound Renal Denervation System (the 'Paradise System') demonstrated positive results in the RADIANCE-HTN TRIO [...]

CHICAGO, IL -- The following information was released by the American Medical Association (AMA): Andis Robeznieks Although patients and physicians have been inundated with information regarding COVID-19, the JAMA Network⢠[...]

- Tammy, a mother and grandmother, who always led an active lifestyle -- going to the gym several times a week -- never thought she would be at risk for [...]

Germany, Nov. 19 -- Veltassa(R) is a well-tolerated1 and effective2 oral calcium potassium binder for the treatment of hyperkalemia supported by 12 month clinical data Veltassa(R) will benefit from Fresenius [...]

Late-breaking data presented at AHA 2020 Scientific Sessions and published simultaneously in Circulation WHIPPANY, N.J. -- Bayer announced today late-breaking data from a pre-specified exploratory subgroup analysis of the FIDELIO-DKD [...]

Regulatory submissions based on positive data from Phase III FIDELIO-DKD study recently published in the New England Journal of Medicine WHIPPANY, N.J. -- Bayer today announced the submission of a [...]

Daewoong Pharmaceutical is one of the pharmaceutical companies that led the combination drug craze in the Korean hypertension treatment market. Daewoong first released Olostar, the world's first combination drug that [...]

AstraZeneca is set to sell the rights to its AT1 subtype angiotensin II receptor antagonist Atacand (candesartan cilexetil) and Atacand Plus (a fixed-dose combination of candesartan cilexetil and hydrochlorothiazide) to [...]

M2 PRESSWIRE-October 30, 2020-: Atacand to be divested to Cheplapharm in more than 70 countries (C)1994-2020 M2 COMMUNICATIONS RDATE:30102020 Agreement supports strategy of focusing on newer medicines in main therapy [...]

Boryung Pharmaceutical is the only local company that has developed a new drug for hypertension. The treatment, known as Kanarb, is an Angiotensin II Receptor Blocker (ARB)-class drug, the most [...]

(GlobeNewswire) - Diffusion Pharmaceuticals Inc. (Nasdaq: DFFN) (Diffusion or the Company), today announced the appointment of Christopher D. Galloway, M.D. to Chief Medical Officer, effective immediately. Dr. Galloway will report [...]

CHARLOTTESVILLE, Va., Oct 19, 2020 (GLOBE NEWSWIRE via COMTEX) -- Diffusion Pharmaceuticals Inc. (Nasdaq: DFFN) ('Diffusion' or 'the Company'), today announced the appointment of Christopher D. Galloway, M.D. to Chief [...]

Confo Therapeutics today announced the selection of its first preclinical drug candidate, CFTX-1554, a compound designed to address peripheral neuropathic pain with the potential to address additional pain indications. Confo [...]

GHENT, Belgium -- Confo Therapeutics today announced the selection of its first preclinical drug candidate, CFTX-1554, a compound designed to address peripheral neuropathic pain with the potential to address additional [...]

ROCKVILLE, MD -- The following information was released by the Heart Failure Society of America (HFSA): Read John C. Burnett, Jr.'s full bio QandA Please share with us some 'highlights' [...]

Recently, a concern raised by regulatory agencies on the presence of nitrosamine impurities observed in drugs such as angiotensin II receptor blockers (ARBs) viz. Valsartan, and other class of drugs [...]

Medicinal chemist Joe Harding was in his lab at Washington State University trying to isolate, purify and clone the protein receptor for the hormone angiotensin II when he noticed something [...]

ROCKVILLE, MD -- The following information was released by the Regulatory Affairs Professionals Society: By Kari Oakes An immediately effective guidance from the US Food and Drug Administration (FDA) details [...]

Byline: Dr. Minali Nigam and Dr. Sanjay Gupta, CNN (CNN) -- One of the more puzzling aspects of the novel coronavirus is just how many organ systems are impacted through [...]

(GlobeNewswire) - La Jolla Pharmaceutical Company (Nasdaq: LJPC) announced today that its Board of Directors has appointed Larry Edwards as President and Chief Executive Officer. Larry has an impressive track [...]

SAN DIEGO, July 28, Jul 28, 2020 (GLOBE NEWSWIRE via COMTEX) -- La Jolla Pharmaceutical Company (Nasdaq: LJPC) announced today that its Board of Directors has appointed Larry Edwards as [...]

An interventional therapy aimed at improving survival chances and reducing the need for critical care treatment due to COVID-19 is being investigated by physicians at The University of Texas Health [...]

Topline findings from the FIDELIO-DKD study show the investigational drug finerenone delayed the progression of chronic kidney disease and reduced risk for cardiovascular events among adults with type 2 diabetes [...]

ROCKVILLE, MD -- The following information was released by the Regulatory Affairs Professionals Society: By Kari Oakes Two manufacturers have announced voluntary recalls of metformin formulations containing elevated levels of [...]

Byline: Amirah Al Idrus Five years after kicking off a massive phase 3 program, Bayer has good news for its heart failure pill finerenone. The drug beat placebo at staving [...]

* Finerenone reduced the combined primary endpoint of risk of chronic kidney disease progression, kidney failure or kidney death versus placebo when added to standard of care * Approximately twenty-nine [...]

SILVER SPRING, MD -- The following information was released by the U.S. Food and Drug Administration (FDA): Patient safety is the FDA's top priority. The U.S. Food and Drug Administration [...]

M2 PRESSWIRE-June 2, 2020-: COVID-19: Swedish company is awarded prestigious grant (C)1994-2020 M2 COMMUNICATIONS RDATE:02062020 In strong competition GAEU's client Vicore Pharma Holding AB (publ) was awarded [pounds sterling] 1.5 [...]

CHESTERBROOK, Jun 02, 2020 (GLOBE NEWSWIRE via COMTEX) -- -- TRV027 is a novel AT1 receptor selective agonist with the potential to treat acute lung injury and ARDS Robust clinical [...]

ROCKVILLE, MD -- The following information was released by the Regulatory Affairs Professionals Society: By Kari Oakes Some extended-release formulations of the diabetes drug metformin contained levels of a nitrosamine [...]

Silver Spring, MD -- The following information was released by the U.S. Food and Drug Administration (FDA): The U.S. Food and Drug Administration is announcing today that agency laboratory testing [...]

Byline: Amy Norton, HealthDay Reporter WEDNESDAY, May 27, 2020 (HealthDay News) -- Many patients with heart failure might live years longer if they were on a combination of newer medications, [...]

Despite the global spread of the new coronavirus, the local pharmaceutical market continued to expand in the first quarter, industry data showed. Healthcare big data provider IQVIA Korea on Friday [...]

Washington: TREVENA, INC., has filed FORM 8K (Current Report) with Securities and Exchange Commission on May 18, 2020: UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT [...]

DUBLIN: Research and Markets has issued the following news release: The 'Type 2 Angiotensin II Receptor - Pipeline Review, H1 2020' drug pipelines has been added to ResearchAndMarkets.com's offering. Type [...]

DUBLIN -- The 'Type 2 Angiotensin II Receptor - Pipeline Review, H1 2020' drug pipelines has been added to ResearchAndMarkets.com's offering. Type 2 Angiotensin II Receptor (Angiotensin II Type 2 [...]

M2 PRESSWIRE-May 19, 2020-: Type 2 Angiotensin II Receptor - Pipeline Review, H1 2020 (C)1994-2020 M2 COMMUNICATIONS RDATE:19052020 The 'Type 2 Angiotensin II Receptor - Pipeline Review, H1 2020' drug [...]

HENNIGSDORF: SphingoTec GmbH has issued the following news release: Diagnostics company SphingoTec GmbH ('sphingotec') and 4TEEN4 Pharmaceuticals GmbH ('4TEEN4') announced today the publication of new data showing that high blood [...]

Byline: Nysa Adurkar The World Hypertension Day is globally celebrated each year on May 17th 1.1 million deaths in India each year. What could have claimed such an inordinate number [...]

FDA-approved option for adult and pediatric patients available in 15 mM per 5 mL, 45 mM per 15 mL and 150 mM per 50 mL presentations LAKE ZURICH, Ill. -- [...]